Recommendations for optimal care of the fragility fracture patient to reduce the risk of future fracture.

The Journal of the American Academy of Orthopaedic Surgeons

Volumn 12, Issue 6, 2004, Pages 385-395

  Bouxsein, Mary L ^a   Kaufman, John ^a   Tosi, Laura ^a   Cummings, Steven ^a   Lane, Joseph ^a   Johnell, Olof ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

AGE; AGED; BONE DENSITY; COMPARATIVE STUDY; ESTROGEN THERAPY; FEMALE; FOLLOW UP; FRACTURE FIXATION; FRACTURE HEALING; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OSTEOPOROSIS; PATHOLOGIC FRACTURE; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT;

AGE FACTORS; AGED; BONE DENSITY; COMBINED MODALITY THERAPY; DIPHOSPHONATES; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; FRACTURE FIXATION; FRACTURE HEALING; FRACTURES, SPONTANEOUS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; RECURRENCE; RISK ASSESSMENT;

EID: 16644379085     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/00124635-200411000-00003     Document Type: Review

References (48)